US 12338450
Gene therapy constructs for treating Wilson disease
granted A61KA61K48/005A61K48/0058
Quick answer
US patent 12338450 (Gene therapy constructs for treating Wilson disease) held by Ultragenyx Pharmaceutical Inc. expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K48/005, A61K48/0058, A61P, A61P43/00